The Prevelance Rate of Human Cytomegalovirus (HCMV), Epstein-Barr Virus (EBV) and Human Herpes Virus (HHV-6) in a Saliva of the Patient With Periodantitis

The recruitment status of this study is unknown because the information has not been verified recently.

Verified October 2010 by Rambam Health Care Campus.
Recruitment status was Recruiting

Sponsor:

Information provided by:

Rambam Health Care Campus

ClinicalTrials.gov Identifier:

NCT01248598

First received: November 21, 2010

Last updated: November 24, 2010

Last verified: October 2010

History of Changes

Purpose

The purpose of this study is to study the prevalence of EBV, HCMV, HHV-6 in saliva and on the toothbrush patient with periodontitis.

Condition
Cytomegalovirus Epstein-Barr Virus Infections Herpesvirus Infection


Study Type:	Observational
Study Design:	Observational Model: Case-Only Time Perspective: Cross-Sectional

Further study details as provided by Rambam Health Care Campus:

Primary Outcome Measures:

The Prevelance Rate of the EBV, HCMV, HHV-6 in saliva [ Time Frame: 1 year ] [ Designated as safety issue: No ]
Check the EBV, HCMV, HHV-6 in saliva by PCR

Secondary Outcome Measures:

change outcomes EBV, HCMV, HHV-6 in saliva before and after toothbrushing [ Time Frame: 1 year ] [ Designated as safety issue: No ]
Check the EBV, HCMV, HHV-6 in saliva by RC-PCR before and after toothbrushing


Estimated Enrollment:	10
Study Start Date:	October 2010

Detailed Description:

Human cytomegalovirus (HCMV), Epstein-Barr virus (EBV) Human Herpes virus6 (HHV-6)

Eligibility


Ages Eligible for Study:	18 Years to 80 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Patient of the Department of Periodontology, School of Graduate Dentistry Rambam Health care campus

Criteria

Inclusion Criteria:

Patient with peridontitis

Exclusion Criteria:

Previous periodontal treatment in last 3 month
Toothbrushing disability

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01248598

Locations


Israel
Department of Periodontology, School of Graduate Dentistry Rambam Health care campus	Recruiting
Haifa, Israel
Contact: Dr. Leon Bilder 0544598769 leonid.bilder@mail.huji.ac.il
Principal Investigator: Leon Bilder, DMD
Sub-Investigator: Eli Machtei, DMD

Sponsors and Collaborators

Rambam Health Care Campus

More Information

No publications provided


Responsible Party:	Department of Periodontology, School of Gradute Dentistry Rambam Health care campus Haifa, Israel
ClinicalTrials.gov Identifier:	NCT01248598 History of Changes
Other Study ID Numbers:	400-10-RMB CTIL
Study First Received:	November 21, 2010
Last Updated:	November 24, 2010
Health Authority:	Israel:IRB

Additional relevant MeSH terms:


Epstein-Barr Virus Infections Herpesviridae Infections DNA Virus Infections Neoplasms	Neoplasms, Experimental Tumor Virus Infections Virus Diseases

ClinicalTrials.gov processed this record on March 01, 2015

To Top